Jenburkt Pharmaceuticals Ltd

Board Meeting Intimation for Taking On Record The Audited Financial Results For The Quarter And Financial Year Ended On 31St March 2025 And To Consider Recommendation Of Dividend If Any.

12:44 PM, 12th May 2025

Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve the audited financial results for the quarter and financial year ended on 31st March 2025 and recommend dividend if any.

Jenburkt Pharmaceuticals Ltd

Board Meeting Intimation for Taking On Record The Audited Financial Results For The Quarter And Financial Year Ended On 31St March 2025 And To Consider Recommendation Of Dividend If Any.

More Jenburkt Pharmaceuticals Ltd Announcements